Tiontaire trasteorann
NACE Rev 2.1 21.10 → coibhéis EMTAK 2025 (Estonia)
Roinneann aicmiú náisiúnta gníomhaíochtaí Cyprus (NACE Rev 2.1) a chnámh droma 4-dhigit le caighdeán NACE Rev 2.1 an AE. Ar an mbonn sin, taispeánaimid an fho-aicme nó na fo-aicmí coibhéiseacha EMTAK 2025 a úsáidtear i Estonia.
Máthair-aicme AE comhroinnte
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21.10
Manufacture of basic pharmaceutical products
21101
Põhifarmaatsiatoodete tootmine
Faoin tiontú seo
Is é NACE Rev 2.1 an t-aicmiú gníomhaíochtaí a úsáidtear i Cyprus. Is é EMTAK 2025 an córas coibhéiseach i Estonia. Is leaganacha náisiúnta de NACE Rev 2.1 an AE iad araon, mar sin is féidir aon fho-aicme 5-dhigit i gcóras amháin a rianú siar go haicme AE 4-dhigit comhroinnte — agus uaidh sin, a theilgean i bhfo-aicmí na tíre eile.
Gineadh an leathanach seo don cheist „NACE Rev 2.1 21.10 go EMTAK 2025“ agus fanann sé sioncronaithe lenár sioncronú míosúil Market Intelligence.